Roivant Sciences, a New York-based healthcare company, and Sumitomo Dainippon Pharma, have signed a definitive agreement for the creation of a broad strategic alliance and to form a new company…
WuXi, Sterling Pharma Expand; Vetter In Industrial Robot Pilot
The latest news from CDMOs, CMOs, and suppliers featuring news from WuXi Biologics, Lonza, Vetter, Sterling Pharma Solutions, and Bio-Techne. Chemicals/Chemical API Manufacturing Sterling Pharma To Invest $1.5 Million in…
FDA Proposes New Mfg Rating System to Address Drug Shortages
The US Food and Drug Administration (FDA) has issued a report on the root causes and potential solutions for drug shortages, including proposing a new system to measure and rate…
J&J Agrees in Principle to Deal in Opioid Litigation; Adjusts Earnings
Johnson & Johnson (J&J) has reached an agreement in principle for $4 billion with certain state attorneys general over opioid litigation and has reduced its previously-reported third-quarter earnings to reflect…
Zentiva To Acquire Select European OTC, Generic Business of Alvogen
Zentiva has agreed to acquire the Central and Eastern European (CEE) business of Alvogen, a provider of generics, biosimilars and over-the-counter (OTC) products, for an undisclosed amount. Zentiva is the…
Roche Extends Tender Offer in $4.3-Billion Spark Acquisition
Roche has extended its tender offer period relating to its pending $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company, from October 30, 2019 to November 25, 2019. Roche had…
Allergan In $750-Million Settlement Over Alzheimer’s Drug Namenda
Allergan and its subsidiaries, Forest Laboratories LLC, Forest Laboratories Inc., and Forest Laboratories Holdings, have reached a settlement of $750 million with a plaintiff class of direct purchasers of Namenda…
Mylan Issues Recall of One Lot of Anti-Anxiety Drug
Mylan Pharmaceuticals is conducting a voluntary nationwide recall in the US of one lot of aprazolam tablets, USP C-IV 0.5 mg, to the consumer level due to the potential presence…
Gilead Sciences and Glympse Bio, a developer of non-invasive technology for disease activity, have entered into a strategic collaboration for nonalcoholic steatohepatitis (NASH) clinical development. Glympse Bio’s proprietary synthetic biomarkers,…
UK Signs Freight-Capacity Deals To Ensure Medicine Delivery Post Brexit
The UK Department of Transportation has signed freight-capacity contracts to help ensure medicines continue to enter the UK after Brexit. UK Transport Secretary Grant Shapps announced that Brittany Ferries, DFDS,…
